We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$427M
AUM Growth
+$34.6M
(+8.8%)
Cap. Flow
+$33M
Cap. Flow
% of AUM
7.75%
Top 10 Holdings %
Top 10 Hldgs %
42.72%
Holding
188
New
25
Increased
60
Reduced
24
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$3.71M |
| 2 |
Apple
AAPL
|
+$3.22M |
| 3 |
Amgen
AMGN
|
+$2.12M |
| 4 |
Eli Lilly
LLY
|
+$2M |
| 5 |
Texas Instruments
TXN
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$1.36M |
| 2 |
Nike
NKE
|
+$865K |
| 3 |
Incyte
INCY
|
+$413K |
| 4 |
Bank of America
BAC
|
+$337K |
| 5 |
Heron Therapeutics
HRTX
|
+$231K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.49% |
| 2 | Technology | 18.61% |
| 3 | Healthcare | 13.85% |
| 4 | Industrials | 10.48% |
| 5 | Consumer Staples | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Thermo Fisher Scientific
TMO
$196B
| $390K | 0.09% |
705
-50
| -7% | -$28.6K |
|
127
Goldman Sachs
GS
$312B
| $387K | 0.09% |
+856
| New | +$376K |
|
128
Energy Transfer Partners
ET
$70B
| $387K | 0.09% |
23,844
+3,725
| +19% | +$58.5K |
|
|
IFN
129
Aberdeen India Fund
IFN
$488M
| $386K | 0.09% |
+21,615
| New | +$393K |
|
130
Genuine Parts
GPC
$16.8B
| $370K | 0.09% |
2,676
| – | – |
|
131
Marathon Petroleum
MPC
$92.2B
| $364K | 0.09% |
2,098
| – | – |
|
132
State Street Energy Select Sector SPDR ETF
XLE
$38.5B
| $352K | 0.08% |
+7,718
| New | +$359K |
|
133
Halliburton
HAL
$29.6B
| $346K | 0.08% |
10,249
| – | – |
|
134
Quest Diagnostics
DGX
$22.8B
| $342K | 0.08% |
2,500
| – | – |
|
135
Target
TGT
$63.1B
| $340K | 0.08% |
2,300
| – | – |
|
136
L3Harris
LHX
$52.4B
| $337K | 0.08% |
1,500
| – | – |
|
137
Truist Financial
TFC
$62.1B
| $336K | 0.08% |
8,644
| – | – |
|
138
iShares MSCI EAFE ETF
EFA
$75.8B
| $334K | 0.08% |
4,269
| – | – |
|
139
CenterPoint Energy
CNP
$28B
| $320K | 0.08% |
+10,334
| New | +$305K |
|
140
MetLife
MET
$59.9B
| $320K | 0.08% |
+4,560
| New | +$326K |
|
141
Tesla
TSLA
$1.39T
| $320K | 0.07% |
1,615
| – | – |
|
142
Clorox
CLX
$11.6B
| $307K | 0.07% |
2,246
| – | – |
|
143
Jefferies Financial Group
JEF
$12.7B
| $299K | 0.07% |
6,000
| – | – |
|
144
Dover
DOV
$28.2B
| $298K | 0.07% |
1,652
+152
| +10% | +$27.2K |
|
145
Cheniere Energy
CQP
$30.7B
| $295K | 0.07% |
6,000
| – | – |
|
146
Sony
SONY
$124B
| $294K | 0.07% |
17,300
| – | – |
|
|
SEE
147
DELISTED
Sealed Air
SEE
| $281K | 0.07% |
8,070
| – | – |
|
148
GSK
GSK
$101B
| $278K | 0.07% |
7,224
+2,500
| +53% | +$105K |
|
149
Citigroup
C
$216B
| $275K | 0.06% |
+4,339
| New | +$268K |
|
150
FirstEnergy
FE
$28B
| $273K | 0.06% |
+7,121
| New | +$276K |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Searle & Co held 188 positions worth $427M, up 8.8% from $392M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Searle & Co deployed $33M of net new capital in Q2 2024, opening 25 new positions and adding to 60 existing holdings. Its largest new stake was Amgen: 7,221 shares worth $2.26M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Nike, an estimated $865K trimmed.
- Searle & Co's largest Q2 2024 buy was Amgen: 7,221 shares worth $2.26M.
- Searle & Co added most to JPMorgan Chase in Q2 2024, an estimated $3.71M increase.
- Searle & Co's biggest Q2 2024 reduction was Nike, cutting an estimated $865K.
- Searle & Co fully exited Baxter International in Q2 2024, selling an estimated $1.36M.
- Searle & Co's ten largest holdings make up 43% of its $427M portfolio in Q2 2024.
- Searle & Co opened 25 new positions and closed 4 in Q2 2024.
- Searle & Co's portfolio value rose 8.8% quarter-over-quarter to $427M.
Based on Searle & Co's 13F filing for Q2 2024, filed 30 Jul 2024.